Skip to content

Lexicomp app: renew or install!

Lexicomp

Lexicomp is a comprehensive clinical drug information app including Lexi-Drugs, a drug interaction tool, and an extensive library of clinical calculators.  Lexicomp is available both via web access and as an app that you can install on your phone, iPad or other handheld device.

The Lexicomp app is free and Himmelfarb Library’s subscription allows you to install Lexicomp‘s high-quality drug information to your phone, iPad, or other handheld device.

App Instructions

  1. Access Lexi-Comp then select the link in the right-hand menu for "Mobile App Access."
  2. Select your platform and if you are a new or existing customer and copy the authorization code provided.

Renewals

  1. Access  http://www.lexi.com/account/code and login with your Lexicomp login/password.
  2. In the Subscriptions section, locate Add a Subscription by Code, then paste the authorization code.
  3. You will receive an email with a 5-character PIN at your registered email address; enter the PIN into the Verify PIN field then click Verify.
  4. Click Finish
  5. On your phone/iPad/handheld, open the Lexicomp app and select ‘Update’.

Lexicomp New Users

  1. Access Lexi-Comp and select the right-hand menu for Mobile App Access.
  2. Create a personal Lexicomp account then login to your Lexicomp account.
  3. Under Add a Subscription by Code, paste the authorization code.
  4. You will receive an email with a 5-character PIN at your registered email address; enter the PIN into the Verify PIN field then click Verify.
  5. Click Finish
  6. On your phone/iPad/handheld, open Lexicomp and login with your Lexicomp login/password; Lexicomp content will automatically load to your iPad.

You can find additional clinical apps on Himmelfarb Library’s App Shelf. Please contact Laura Abate (leabate@gwu.edu) with questions.

Leave a Reply

Your email address will not be published. Required fields are marked *

GW is committed to digital accessibility. If you experience a barrier that affects your ability to access content on this page, let us know via the Accessibility Feedback Form.